Measles immunization in HIV-infected children

Pediatrics

Volumn 103, Issue 5 I, 1999, Pages 1057-1060

  Halsey, N A ^a   Abramson, J S ^a   Chesney, P J ^a   Fisher, M C ^a   Gerger, M A ^a   Marcy, S M ^a   Murray, D L ^a   Overturf, G D ^a   Prober, C G ^a   Weiner, L B ^a   Whitley, R J ^a   Yogev, R ^a   Wilfert, C ^a   Aronson, J E ^a   Beck, D T ^a   Fleischman, A R ^a   Kline, M W ^a   Mofenson, L M ^a   Scott, G B ^a   Wara, D W ^a   Whitley Williams, P N ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MEASLES; MEASLES VACCINATION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; HEALTH POLICY; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; PNEUMONIA, VIRAL; RUBELLA VACCINE; UNITED STATES; VACCINES, COMBINED;

EID: 0033042440     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.103.5.1057     Document Type: Review

References (25)

1. Centers for Disease Control and Prevention. Measles in HIV-infected children, United States. MMWR Morb Mortal Wkly Rep. 1988;37:183-186
2. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA. 1992;267:1237-1241
3. Sension MG, Quinn T, Markowitz LE, et al. Measles in hospitalized children infected with human immunodeficiency virus. Am J Dis Child. 1988;142:1271-1272
4. Friedman S. Measles in New York City. JAMA. 1991;266:1220
5. Centers for Disease Control and Prevention. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection: 1993. MMWR Morb Mortal Wkly Rep. 1996;45:603-606
6. American Academy of Pediatrics. Measles. In: Peter G, ed. 1997 Red Book. Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:348-350
7. Enders JF, McCarthy K, Mitus A, Cheatham WJ. Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash. N Engl J Med. 1959;261:875-881
8. Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute leukemia. Am J Dis Child. 1962;103:413-418
9. Nadel S, McGann K, Hodinka RL, Rutstein R, Chatten J. Measles giant cell pneumonia in a child with human immunodeficiency virus Infection. Pediatr Infect Dis J. 1991;10:542-544
10. Markowitz LE, Chandler FW, Roldan EO, et al. Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis. 1988;158:480-483
11. Embree JE, Datta P, Stackiw W, et al. Increased risk of early measles in infants with human immunodeficiency virus type 1-seropositive mothers. J Infect Dis. 1992;165:262-267
12. Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA. 1989;261: 2512-2516
13. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus - infected children. Pediatr Infect Dis J. 1992;11:1008-1014
14. Brena AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr. 1993;6:1125-1129
15. Walter EB, Katz SL, Bellini WJ. Measles immunity in HIV-infected children. Pediatr AIDS HIV Infect. 1994;5:300-304
16. Al-Attar I, Reisman J, Muehlmann M, McIntosh K. Decline of measles antibody titers after immunization in human immunodeficiency virus - infected children. Pediatr Infect Dis J. 1995;14:149-151
17. Arpadi SM, Markowitz LE, Baughman AL, et al. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics. 1996;97:653-657
18. Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. J Pediatr. 1994;125:72-74
19. El-Sadr W, Oleske JM, Agins BE, et al. Clinical Practice Guideline Number 7. Evaluation and Management of Early HIV Infection. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, January 1994; AHCPR publication 94-0572
20. American Academy of Pediatrics, Committee on Pediatric AIDS. Evaluation and medical treatment of the HIV-exposed infant. Pediatrics. 1997;99:909-917
21. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1995;44(RR-4):1-11
22. + lymphocytes in infants and children exposed to or infected with human immunodeficiency virus. Clin Infect Dis. 1995; 21(suppl 1):S134-S135
23. + lymphocytes in adults and adolescents infected with human immunodeficiency virus. Clin Infect Dis. 1995; 21(suppl 1):S126-S127
24. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep. 1994;43(RR-12):1-19
25. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17):1-19